ScreenerHero

NSHS Nanosphere Health Sciences Inc

CNQ · CA · Healthcare · Biotechnology · nanospherehealth.com
0.0200CAD0.00%Mkt Cap: 149661 $P/E: —

NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap149.66K USD
Enterprise Value204.83K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-61.74K USD
Revenue/Share—
Last Price0.0200 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA63010P2098
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.02000% of range0.0350
52W High0.0350 CAD
52W Low0.0200 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE6.28%
ROA-503.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.73K USD
CapEx (TTM)—
FCF Margin—
FCF Yield-58.97%
Net Debt55.17K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.05
Current Ratio0.01
Quick Ratio0.01
Book Value/Sh-0.19 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 7, 2021
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.10.28M
Float6.96M
Insiders32.29%
Institutions0.00%
Short Interest
Short Ratio8.8d
Short % Out.0.43%
Shares Short612
Short (prev mo.)1.38K
Technical
SMA 500.0200 (-0.0%)
SMA 2000.0225 (-11.1%)
Beta1.01
S&P 52W Chg16.45%
Avg Vol (30d)376
Avg Vol (10d)0
Technical Indicators
RSI (14)39.0
MACD-0.0005
MACD Signal-0.0005
MACD Hist.+0.0000
BB Upper0.0200 CAD
BB Middle0.0200 CAD
BB Lower0.0200 CAD
BB Width0.00%
ATR (14)0.0002 CAD
Vol Ratio (20d)0.00x